Your browser version may not work well with NCBI's Web applications. More information here...
1: Chemotherapy. 2000 Mar-Apr;46(2):150-2.Click here to read Links

Adequate levofloxacin treatment schedules for uterine cervicitis caused by Chlamydia trachomatis.

Mikamo H, Sato Y, Hayasaki Y, Hua YX, Tamaya T.

Department of Obstetrics and Gynecology, School of Medicine, Gifu University, Gifu, Japan. mikamo@cc.gifu-u.ac.jp

The in vivo efficacy of levofloxacin (LVFX), one of the most standard new quinolone antimicrobial agents, in the different treatment schedules of Chlamydia trachomatis uterine cervicitis in women was evaluated. Cervical C. trachomatis was detected by polymerase chain reaction. LVFX at a dosage of 300 mg t.i.d. for 5, 7 and 14 days was orally administered to 18, 33 and 35 Japanese patients, respectively. The eradication rate and the recurrence rate in the different treatment schedules of C. trachomatis were evaluated. The eradication rate in 5-, 7- or 14-day cases was 44.4, 87.9 or 88.6%, respectively. The recurrence rate of 5-, 7- or 14-day cases was 50.0, 0 or 0%, respectively. Seven-day treatment with LVFX is adequate for and effective in C. trachomatis uterine cervicitis. Copyright 2000 S. Karger AG, Basel.

PMID: 10671767 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Levofloxacin (Levaquin® )

    Levofloxacin is used to treat certain infections such as pneumonia chronic bronchitis and sinus, urinary tract, kidney, prostate (a male reproductive gland), and skin infections. Levofloxacin is also used to prevent anth...

  • Ofloxacin (Floxin® )

    Ofloxacin is used to treat certain infections including bronchitis, pneumonia, and infections of the skin, bladder, urinary tract, reproductive organs, and prostate (a male reproductive gland). Ofloxacin is in a class of...

  • Source: AHFS Consumer Medication Information